MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-PB-20-0020511
Noxxon Pharmaceuticals Private Limited
Noxxon Pharmaceuticals Private Limited - pharma in Mohali, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4.07 Cr
▲ 44% YoY
Net profit · FY 2024
₹98,156
Net margin 0.2%
EBITDA · FY 2024
₹2.8 Lakh
EBITDA margin 0.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹60 Lakh
Satisfied ₹30 Lakh
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Noxxon Pharmaceuticals Private Limited
Data last updated:
Noxxon Pharmaceuticals Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24239PB2021PTC053565. Its GSTIN is 03AAHCN6323K1ZH (Punjab). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Satish Kumar Bansal and Sahil Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #644 B Phase XI Sector 65, Mohali, Punjab, India – 160062.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.07 Cr, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹98,156 (net margin 0.2%) and EBITDA of ₹2.8 Lakh (EBITDA margin 0.7%).
As per MCA filings, the company has open charges of ₹60 Lakh and satisfied charges of ₹30 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
Noxxon Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0020511).
Company details
CIN U24239PB2021PTC053565
Registration Number 053565
Incorporation Date 07 June 2021
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-PB-20-0020511
Recognitions & Rankings of Noxxon Pharmaceuticals
Contact details
Noxxon Pharmaceuticals Private Limited's registered office is in Mohali, Punjab. Its e-mail address is in the company report.
- Email
- Registered Address#644 B Phase XI Sector 65, Mohali, Punjab, India – 160062
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Noxxon Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Noxxon Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Noxxon Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Noxxon Pharmaceuticals Private Limited, buy the company report.
Financials of Noxxon Pharmaceuticals Private Limited
FY 2025 filings availableNoxxon Pharmaceuticals Private Limited reported revenue of ₹4.07 Cr (up 44% YoY) for FY 2024.
Revenue · FY 2024
₹4.07 Cr ▲ 44%
Net profit · FY 2024
₹98,156 margin 0.2%
EBITDA · FY 2024
₹2.8 Lakh margin 0.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 44%
EBITDA CAGR growth
1 year
▼ 12%
Revenue rose 44% in the latest year. EBITDA fell 12% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.8 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹98,156 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.7% | ||
| Net Profit Margin | 0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Noxxon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Noxxon Pharmaceuticals Private Limited
Noxxon Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Kumar Bansal | Director | 07 Jun 2021 | 5 Years 4 Months | Current |
| Sahil Bansal | Director | 07 Jun 2021 | 5 Years 4 Months | Current |
Charges & borrowings
Open charges
₹60 Lakh
Satisfied charges
₹30 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Feb 2024 | 100875619 | Hdfc Bank Limited | ₹60 Lakh | Open | |
| 19 Feb 2022 | 100536667 | Others | ₹30 Lakh | Satisfied |
To see the full charge records of Noxxon Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Noxxon Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Noxxon Pharmaceuticals. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, SAS Nagar, Punjab | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
To see the full case history of Noxxon Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Noxxon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Noxxon Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
Active EPFO establishments
1
GST
Noxxon Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAHCN6323K1ZH | Punjab | Active | 10 Aug 2021 |
| 06AAHCN6323K1ZB | Haryana | Active | 01 Jan 2022 |
To see the full GST registrations and return filing status of Noxxon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Noxxon Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Sahil Bansal was appointed as Director on 07 Jun 2021.
Charges
A charge with Hdfc Bank Limited of Rs. 60.00 Lakh registered on 17 Feb 2024 with Charge ID 100875619 was modified on 10 Feb 2026.
AGM
Noxxon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Noxxon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 60.00 Lakh with Charge ID 100875619 was registered on 17 Feb 2024.
Charges
A charge registered on 19 Feb 2022 via Charge ID 100536667 with Others was fully satisfied on 19 Jan 2024.
Charges
A charge with Others amounted to Rs. 30.00 Lakh with Charge ID 100536667 was registered on 19 Feb 2022.
Appointed
Sahil Bansal was appointed as Director.
Appointed
Satish Kumar Bansal was appointed as Director.
Incorporation
07 Jun 2021
Noxxon Pharmaceuticals Private Limited was registered on 07 Jun 2021 with Roc Chandigarh & aged 5 years 4 months as per MCA records.
Frequently asked questions
Noxxon Pharmaceuticals is an active private limited company based in Mohali, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 June 2021 (5+ years old) and is registered under CIN U24239PB2021PTC053565.
Noxxon Pharmaceuticals has 2 current directors:
- Satish Kumar Bansal - Director
- Sahil Bansal - Director
The latest financial statements of Noxxon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Noxxon Pharmaceuticals is 03AAHCN6323K1ZH, registered in Punjab. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAHCN6323K1ZB (Haryana).
The CIN (Corporate Identification Number) of Noxxon Pharmaceuticals is U24239PB2021PTC053565. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Noxxon Pharmaceuticals has 1 court case on record: 1 filed by the company.
Noxxon Pharmaceuticals was incorporated on 07 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chandigarh.
Sahil Bansal was appointed as Director on 07 Jun 2021. Satish Kumar Bansal was appointed as Director on 07 Jun 2021.
Yes, Noxxon Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-20-0020511).
The registered office of Noxxon Pharmaceuticals is at #644 B Phase XI Sector 65, Mohali, Punjab, India – 160062.